Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

Natera (NTRA) PT Raised to $100 at BTIG, Remains Top Pick, 'Natera hits this one out of the park'

February 29, 2024 6:36 AM EST

BTIG analyst Mark Massaro raised the price target on Natera (NASDAQ: NTRA) to $100.00 (from $90.00) while maintaining a Buy rating.

The analyst comments "NTRA exceeded its pre-announced Q4 rev results by ~$11M and delivered robust +43% Y/Y rev growth in Q4 and +32% Y/Y for 2023.... More